CLINICAL_TRIALS trial_result · 2026-03-23

Clinical Trial Update: Phase 2 Study to Evaluate RPT193 in Adults With Moderate to Severe T2-high Asthma [Phase 2]

The Phase 2 study evaluating RPT193 in adults with moderate to severe T2-high asthma was terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: RAPT Therapeutics, Inc. | Conditions: Asthma | Phase 2 | Status: TERMINATED | Results posted: 2026-03-23